$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

$thmo Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922007409 Filed on March 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$2.418M	$9.294M	$1.950M
YoY Change	24.0%	-4.62%	13.37%
Cost Of Revenue	$1.734M	$5.801M	$1.060M
YoY Change	63.58%	-31.63%	-6.19%
Gross Profit	$684.0K	$3.493M	$890.0K
YoY Change	-23.15%	177.44%	50.85%
Gross Profit Margin	28.29%	37.58%	45.64%
Selling, General & Admin	$1.344M	$8.515M	$1.760M
YoY Change	-23.64%	10.92%	-44.83%
% of Gross Profit	196.49%	243.77%	197.75%
Research & Development	$665.0K	$2.209M	$540.0K
YoY Change	23.15%	-10.82%	-15.63%
% of Gross Profit	97.22%	63.24%	60.67%
Depreciation & Amortization	$156.0K	$633.0K	$170.0K
YoY Change	-8.24%	-14.69%	-19.05%
% of Gross Profit	22.81%	18.12%	19.1%
Operating Expenses	$2.009M	$10.72M	$2.300M
YoY Change	-12.65%	5.61%	-39.95%
Operating Profit	-$1.325M	-$7.231M	-$1.410M
YoY Change	-6.03%	-18.71%	-56.48%
Interest Expense	-$1.530M	$6.103M	-$1.530M
YoY Change	0.0%	-22.82%	59.38%
% of Operating Profit
Other Income/Expense, Net	-$31.00K	$802.0K	$0.00
YoY Change		15940.0%	-100.0%
Pretax Income	-$2.886M	-$11.85M	-$2.950M
YoY Change	-2.17%	-29.16%	-29.76%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.654M	-$11.88M	-$2.850M
YoY Change	-6.88%	-29.33%	-29.63%
Net Earnings / Revenue	-109.76%	-127.82%	-146.15%
Basic Earnings Per Share		-$43.41
Diluted Earnings Per Share	-$222.8K	-$964.6K	-$359.4K
COMMON SHARES
Basic Shares Outstanding	11.91M	262.1K	7.796M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.280M	$7.280M	$7.160M
YoY Change	1.68%	1.68%	126.58%
Cash & Equivalents	$7.280M	$7.280M	$7.161M
Short-Term Investments
Other Short-Term Assets	$1.578M	$1.578M	$880.0K
YoY Change	79.32%	79.32%	-45.0%
Inventory	$5.373M	$5.373M	$5.877M
Prepaid Expenses
Receivables	$733.0K	$733.0K	$1.382M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.96M	$14.96M	$15.30M
YoY Change	-2.18%	-2.2%	60.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.261M	$1.832M	$1.424M
YoY Change	-11.45%	-14.79%	-29.78%
Goodwill	$781.0K		$781.0K
YoY Change	0.0%		0.0%
Intangibles	$1.318M		$1.358M
YoY Change	-2.95%		-7.43%
Long-Term Investments
YoY Change
Other Assets	$48.00K	$1.757M	$48.00K
YoY Change	0.0%	39.44%	-77.98%
Total Long-Term Assets	$5.688M	$5.688M	$5.562M
YoY Change	2.27%	2.3%	-2.3%
TOTAL ASSETS
Total Short-Term Assets	$14.96M	$14.96M	$15.30M
Total Long-Term Assets	$5.688M	$5.688M	$5.562M
Total Assets	$20.65M	$20.65M	$20.86M
YoY Change	-1.0%	-1.0%	37.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.280M	$1.280M	$1.366M
YoY Change	-6.3%	-6.57%	-5.6%
Accrued Expenses	$2.785M	$2.785M	$2.430M
YoY Change	14.61%	14.61%	12.5%
Deferred Revenue	$719.0K		$608.0K
YoY Change	18.26%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$813.0K	$813.0K	$450.0K
YoY Change	80.67%	80.67%
Total Short-Term Liabilities	$6.348M	$6.348M	$6.143M
YoY Change	3.34%	3.39%	-8.11%
LONG-TERM LIABILITIES
Long-Term Debt	$9.245M	$9.245M	$6.630M
YoY Change	39.44%	39.44%	34.48%
Other Long-Term Liabilities	$20.00K	$1.662M	$20.00K
YoY Change	0.0%	-25.14%	0.0%
Total Long-Term Liabilities	$20.00K	$10.91M	$20.00K
YoY Change	0.0%	23.24%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.348M	$6.348M	$6.143M
Total Long-Term Liabilities	$20.00K	$10.91M	$20.00K
Total Liabilities	$17.26M	$16.82M	$14.99M
YoY Change	15.11%	11.71%	4.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$264.7M		-$253.3M
YoY Change	4.49%		6.9%
Common Stock	$12.00K		$9.000K
YoY Change	33.33%		200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.828M	$3.828M	$5.800M
YoY Change
Total Liabilities & Shareholders Equity	$20.65M	$20.65M	$20.86M
YoY Change	-1.0%	-1.0%	37.11%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$2.654M	-$11.88M	-$2.850M
YoY Change	-6.88%	-29.33%	-29.63%
Depreciation, Depletion And Amortization	$156.0K	$633.0K	$170.0K
YoY Change	-8.24%	-14.69%	-19.05%
Cash From Operating Activities	-$326.0K	-$6.620M	-$2.530M
YoY Change	-87.11%	-54.01%	-1073.08%
INVESTING ACTIVITIES
Capital Expenditures	-$29.00K	$93.00K	$0.00
YoY Change		304.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$29.00K	-$93.00K	$0.00
YoY Change		304.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$6.832M	5.260M
YoY Change	-100.0%	-60.79%	5160.0%
NET CHANGE
Cash From Operating Activities	-326.0K	-$6.620M	-2.530M
Cash From Investing Activities	-29.00K	-$93.00K	0.000
Cash From Financing Activities	0.000	$6.832M	5.260M
Net Change In Cash	-355.0K	$119.0K	2.730M
YoY Change	-113.0%	-96.04%	658.33%
FREE CASH FLOW
Cash From Operating Activities	-$326.0K	-$6.620M	-$2.530M
Capital Expenditures	-$29.00K	$93.00K	$0.00
Free Cash Flow	-$297.0K	-$6.713M	-$2.530M
YoY Change	-88.26%	-53.43%	-1073.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Location AuditorLocation	New York, NY
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	156000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	214000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11911784
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11911784
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8934952
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8934952
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7280000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7161000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	733000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1382000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	5373000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	5877000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1578000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	878000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	14964000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	15298000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1709000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1221000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1261000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1424000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	571000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	730000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	781000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	781000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1318000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1358000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48000	USD
CY2021Q4	us-gaap	Assets Assets	20652000	USD
CY2020Q4	us-gaap	Assets Assets	20860000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1280000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1366000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	348000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	349000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	719000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	608000	USD
CY2021Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	2231000	USD
CY2020Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	2082000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	447000	USD
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	813000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	957000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1291000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6348000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6143000	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	9245000	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	5935000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	493000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	199000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	398000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	604000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1244000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1596000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	17255000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	14990000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	268447000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	259058000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-264662000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253283000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	31000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3828000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5800000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-431000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	70000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3397000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5870000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20652000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20860000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9294000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9744000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5801000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8485000	USD
CY2021	us-gaap	Gross Profit GrossProfit	3493000	USD
CY2020	us-gaap	Gross Profit GrossProfit	1259000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8515000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7677000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2209000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2477000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	10724000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	10154000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7231000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-8895000	USD
CY2021	us-gaap	Interest Expense InterestExpense	6103000	USD
CY2020	us-gaap	Interest Expense InterestExpense	7908000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	652000	USD
CY2021	thmo	Employee Retention Tax Credit And Other Income Expense EmployeeRetentionTaxCreditAndOtherIncomeExpense	802000	USD
CY2020	thmo	Employee Retention Tax Credit And Other Income Expense EmployeeRetentionTaxCreditAndOtherIncomeExpense	-8000	USD
CY2021	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-4649000	USD
CY2020	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-7916000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-11880000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16811000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-501000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-460000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11379000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16351000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-11880000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16811000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11865000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-16797000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-501000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-460000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11364000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16337000	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.60
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11796065
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6277986
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5870000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2560000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15000	USD
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-11880000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3397000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	880000	USD
CY2020	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	32000	USD
CY2020	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1651000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	4981000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	368000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10839000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-16811000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5870000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-11880000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16811000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	633000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	742000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2560000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	880000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3631000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5558000	USD
CY2021	thmo	Inventory Change In Reserve InventoryChangeInReserve	864000	USD
CY2020	thmo	Inventory Change In Reserve InventoryChangeInReserve	3308000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-56000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-12000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-118000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	652000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-703000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	90000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1031000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6582000	USD
CY2019	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P1Y6M25D
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	700000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	106000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-74000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-76000	USD
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	149000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	213000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	61000	USD
CY2021	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	111000	USD
CY2020	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	-12000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-323000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1128000	USD
CY2021	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-554000	USD
CY2020	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-456000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6620000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14393000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4287000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	33000	USD
CY2021	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	6832000	USD
CY2020	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	10839000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1683000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	646000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6832000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17422000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	119000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3004000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7161000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4157000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7280000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7161000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2322000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2379000	USD
CY2020	thmo	Recording Of Beneficial Conversion Feature On Debt RecordingOfBeneficialConversionFeatureOnDebt	4981000	USD
CY2021	thmo	Transfer Of Inventory To Fixed Assets TransferOfInventoryToFixedAssets	181000	USD
CY2020	thmo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	599582
CY2020	thmo	Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice	2.81
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1116484
CY2020Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	37.27
CY2020	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P0Y5M26D
CY2020Q4	thmo	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	1046631
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1244000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	215000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2453000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7280000	USD
CY2021Q4	thmo	Working Capital WorkingCapital	8616000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1596000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but <em style="font: inherit;">not</em> limited to, the allowance for doubtful accounts, carrying amounts of inventories, depreciation and amortization, warranty obligations, assumptions made in valuing financial instruments issued in various compensation and financing arrangements, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company’s consolidated financial statements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1095000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1358000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	32000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1709000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1221000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11850000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-30000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-16728000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-83000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	32000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	32000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	32000	USD
CY2021Q4	thmo	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	47000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	175000	USD
CY2020Q4	thmo	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights	34.42
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31056000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-72000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	197000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Credit Risk</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company’s customers. The Company believes that adequate provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has <em style="font: inherit;">not</em> experienced significant credit related losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Reclassifications</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did <em style="font: inherit;">not</em> have an impact on net loss as previously reported. For the year ended <em style="font: inherit;"> December 31, 2021, </em>sales and marketing and general and administrative expenses were combined into <em style="font: inherit;">one</em> line item identified as sales, general and administrative expenses on the Statement of Operations; the loss on equity method investments was combined with other income on the Statement of Operations; and incentive stock options and foreign rate differential were broken out as separate line items in the reconciliation of federal income tax attributable to operations in Note <em style="font: inherit;">14.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1716066
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	154000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	277000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8089000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7823000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6828000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6399000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1261000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1424000	USD
CY2021	us-gaap	Depreciation Depreciation	429000	USD
CY2020	us-gaap	Depreciation Depreciation	516000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1467000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	781000	USD
CY2020	thmo	Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss	109000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1358000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	781000	USD
CY2021	thmo	Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss	40000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1318000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	781000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1291000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1116000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	175000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2434000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1116000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1318000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1310000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1095000	USD
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	65000	USD
CY2020	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	71000	USD
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	149000	USD
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	212000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	571000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	730000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	398000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	604000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.22	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.22	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	319000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	328000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	139000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	786000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	182000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	604000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	311000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	311000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	105000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	139000	USD
CY2021	us-gaap	Lease Cost LeaseCost	416000	USD
CY2020	us-gaap	Lease Cost LeaseCost	450000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	310000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	301000	USD
CY2019Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	25.23
CY2021	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-3000	USD
CY2020	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	18000	USD
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	67000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	154000	USD
CY2020Q3	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	1000000	USD
CY2020	thmo	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm	P0Y6M14D
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1116484
CY2020Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	37.27
CY2020	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P0Y5M26D
CY2021	thmo	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod	-463236
CY2021	thmo	Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice	80
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	653248
CY2021Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	6.97
CY2021	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P1Y4M24D
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2560000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	880000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2560000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	880000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	565500
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.94
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9294000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9744000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	608000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	620000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	719000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	608000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	889636
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.57
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	766
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	272.21
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	535450
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.89
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	353420
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.04
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	326596
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	12.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	279520
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.29
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.16	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0054	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.05
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8940655
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9307017
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1958000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1493000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	529000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	385000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	337000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4702000	USD
CY2021	thmo	Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount	1282000	USD
CY2020	thmo	Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount	1619000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-195000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-31000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	26000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	13000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	92000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1261000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1424000	USD
	thmo	Employee Retention Tax Credit EmployeeRetentionTaxCredit	842000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2495000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3530000	USD
CY2020	thmo	Effective Income Tax Rate Reconciliation Intangible Assets Amount EffectiveIncomeTaxRateReconciliationIntangibleAssetsAmount	69000	USD
CY2021	thmo	Effective Income Tax Rate Reconciliation Debt Forgiveness Amount EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount	-137000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	257000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	56000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-72000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	197000	USD
CY2021	thmo	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount	1242000	USD
CY2020	thmo	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount	1558000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27088000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27312000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	2797000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	2852000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	437000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	369000	USD
CY2021Q4	thmo	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	127000	USD
CY2020Q4	thmo	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	160000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	313000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	366000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	449000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	234000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	213000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	268000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31424000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31561000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	320000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	352000	USD
CY2021Q4	thmo	Deferred Tax Liabilities Lease Asset DeferredTaxLiabilitiesLeaseAsset	120000	USD
CY2020Q4	thmo	Deferred Tax Liabilities Lease Asset DeferredTaxLiabilitiesLeaseAsset	153000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	440000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	505000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30984000	USD
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	135000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	147000	USD

Files In Submission

Name	View Source	Status
0001437749-22-007409-index-headers.html	Edgar Link	pending
0001437749-22-007409-index.html	Edgar Link	pending
0001437749-22-007409.txt	Edgar Link	pending
0001437749-22-007409-xbrl.zip	Edgar Link	pending
ex_350225.htm	Edgar Link	pending
ex_350226.htm	Edgar Link	pending
ex_350227.htm	Edgar Link	pending
ex_350228.htm	Edgar Link	pending
ex_351927.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thmo-20211231.xsd	Edgar Link	pending
thmo-20211231_cal.xml	Edgar Link	unprocessable
thmo-20211231_def.xml	Edgar Link	unprocessable
thmo-20211231_lab.xml	Edgar Link	unprocessable
thmo-20211231_pre.xml	Edgar Link	unprocessable
thmo20211231_10k.htm	Edgar Link	pending
thmo20211231_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

2021 Q4 Form 10-K Financial Statement

#000143774922007409 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO ThermoGenesis Holdings, Inc. Stock $thmo

2021 Q4 Form 10-K Financial Statement

#000143774922007409 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo